Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Plos Genetics|December 2, 2008
AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targetsAlessandro Gardini, Matteo Cesaroni, Lucilla Luzi, et al.
The Journal of Experimental Medicine|November 30, 2018
Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilitiesMichela Serresi, Bjorn Siteur, Danielle Hulsman, et al.
Nature Neuroscience|November 10, 2015
G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transitionGeoffroy Laumet, Judit Garriga, Shao-Rui Chen, et al.
Lupus|February 25, 2021
Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibitionLoqmane Seridi, Matteo Cesaroni, Ashley Orillion, et al.
Cancer Cell|January 15, 2016
Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung CancerMichela Serresi, Gaetano Gargiulo, Natalie Proost, et al.
Cancer Research|August 15, 2013
Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53Silvia Licciulli, Jacqueline L Avila, Linda Hanlon, et al.
Iscience|July 17, 2023
CSL362 potently and specifically depletes pDCs <i>in</i><i>vitro</i> and ablates SLE-immune complex-induced IFN responsesKatherine A Monaghan, Alberta Hoi, Cristina Gamell, et al.
The Journal of Allergy and Clinical Immunology|June 6, 2017
Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivityHadi Maazi, Homayon Banie, German R Aleman Muench, et al.
Journal of the National Cancer Institute|November 17, 2015
Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid LeukemiaJumpei Yamazaki, Rodolphe Taby, Jaroslav Jelinek, et al.
The Lancet. Rheumatology|January 26, 2024
First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trialJarrat Jordan, Jacqueline Benson, Walter Winn Chatham, et al.
Pageof 4